Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
26,272
Sort by:
Abilify - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Abilify API intelligence over Abilify and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Acne vulgaris - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Acne vulgaris Key assessments Patient Segmentation in Acne vulgaris Acne vulgaris Risk & Burden Factors driving growth in a specific Acne vulgaris patient population
January 2022
60 pages
Acne Vulgaris - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Pipeline Analysis Acne Vulgaris (AV) Market Size and Trends Acne Vulgaris (AV) Market Opportunities Impact of upcoming Therapies in Acne Vulgaris (AV) Acne Vulgaris (AV) Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Acne ...
January 2022
200 pages
Actinic Keratosis - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Keratosis Pipeline Analysis Actinic Keratosis Market Size and Trends Actinic Keratosis Market Opportunities Impact of upcoming Therapies in Actinic Keratosis Actinic Keratosis Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2022
200 pages
Adderall - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Adderall API intelligence over Adderall and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
alimta - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Alimta API intelligence over Alimta and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Alopecia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Alopecia Key assessments Patient Segmentation in Alopecia Alopecia Risk & Burden Factors driving growth in a specific Alopecia patient population
January 2022
60 pages
Ambisome - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Ambisome API intelligence over Ambisome and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Amitiza - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Amitiza API intelligence over Amitiza and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Asthma - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Asthma Key assessments Patient Segmentation in Asthma Asthma Risk & Burden Factors driving growth in a specific Asthma patient population
January 2022
60 pages
Atripla - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Atripla API intelligence over Atripla and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Baraklyud - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Baraklyud API intelligence over Baraklyud and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Bepanthene - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Bepanthene API intelligence over Bepanthene and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Caduet - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Caduet API intelligence over Caduet and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Candidiasis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Candidiasis Key assessments Patient Segmentation in Candidiasis Candidiasis Risk & Burden Factors driving growth in a specific Candidiasis patient population
January 2022
60 pages
Cansidas - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Cansidas API intelligence over Cansidas and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Chemotherapy Induced Nausea and Vomiting - Epidemiology Forecast to 2032
US$ 3,950.00
... Forecast 7MM Coverage Total Cases in Chemotherapy Induced Nausea and Vomiting Key assessments Patient Segmentation in Chemotherapy Induced Nausea and Vomiting Chemotherapy Induced Nausea and Vomiting Risk & Burden Factors driving growth in a specific Chemotherapy Induced Nausea and Vomiting patient population ...
January 2022
60 pages
Chronic Heart Failure - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Chronic Heart Failure Key assessments Patient Segmentation in Chronic Heart Failure Chronic Heart Failure Risk & Burden Factors driving growth in a specific Chronic Heart Failure patient population
January 2022
60 pages
Cialis - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Cialis API intelligence over Cialis and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Colcrys - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Colcrys API intelligence over Colcrys and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Combivir - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Combivir API intelligence over Combivir and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Concerta - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Concerta API intelligence over Concerta and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Copaxone - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Copaxone API intelligence over Copaxone and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Diprivan EML - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Diprivan EML API intelligence over Diprivan EML and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Efient - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Efient API intelligence over Efient and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Erectile Dysfunction - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Erectile Dysfunction Key assessments Patient Segmentation in Erectile Dysfunction Erectile Dysfunction Risk & Burden Factors driving growth in a specific Erectile Dysfunction patient population
January 2022
60 pages
Esophageal Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Esophageal Cancer Key assessments Patient Segmentation in Esophageal Cancer Esophageal Cancer Risk & Burden Factors driving growth in a specific Esophageal Cancer patient population
January 2022
60 pages
Eviplera - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Eviplera API intelligence over Eviplera and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Exjade - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Exjade API intelligence over Exjade and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Fabry Disease - Epidemiology Forecast to 2032
US$ 3,950.00
... epidemiology historical and forecasted data of Fabry Disease prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease ... Fabry Disease market. Identifying prevalent patient populations as well as risk factors in the global Fabry Disease ...
January 2022
60 pages
Fampyra - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Fampyra API intelligence over Fampyra and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Fosamax - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Fosamax API intelligence over Fosamax and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Fumarate De Formoterol - API Insight, 2022
US$ 500.00
... advantage by identifying the key patent expiry details with respect to Fumarate De Formoterol API intelligence over Fumarate De Formoterol and gaining primary intelligence over Active Ingredient manufacturers by country Make more ...
January 2022
30 pages
Fusilev - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Fusilev API intelligence over Fusilev and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Gasmotin - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Gasmotin API intelligence over Gasmotin and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Gaster D - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Gaster D API intelligence over Gaster D and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Gemzar - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Gemzar API intelligence over Gemzar and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Geninax - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Geninax API intelligence over Geninax and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Graceptor - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Graceptor API intelligence over Graceptor and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
